Literature DB >> 20392990

Molecular characterization of invasive subpopulations from an esophageal squamous cell carcinoma cell line.

Yu-Kuei Chen1, Wun-Shaing Wayne Chang, I-Chen Wu, Ling-Hui Li, Sheau-Fang Yang, Jeff Yi-Fu Chen, Ming-Chung Hsu, Shih-Hsien Chen, Deng-Chyang Wu, Jang-Ming Lee, Chun-Hsiung Huang, Yih-Gang Goan, Shah-Hwa Chou, Chia-Tsuan Huang, Ming-Tsang Wu.   

Abstract

BACKGROUND: Once diagnosed, esophageal cancer has a very low overall 5-year survival rate. This study investigates the mechanisms behind the invasiveness and severity of esophageal squamous cell carcinoma (ESCC).
MATERIALS AND METHODS: Transwell invasion chamber was used to subdivide one Taiwanese ESCC cell line, CE81T/VGH, into sublines (CE81T-0, CE81T-1, CE81T-2, CE81T-3, and CE81T-4) in four rounds of assays; the most invasive were identified, and various factors related to their invasiveness measured.
RESULTS: CE81T-1, CE81T-2, CE81T-3 and CE81T-4 sublines were significantly more invasive than the parental cells (CE81T/VGH) and CE81T-0 subline. CE81T-1 and CE81T-4, the sublines we chose to study further, had significantly greater colony-forming ability (3.5- to 2.7-fold) and wound migrating activity (1.95- to 2.6-fold) than the parental cells in vitro (p<0.01). They also displayed greater tumorigenesis in immunodeficient BALB/c Foxlnn mice than the parental cells. We found an inverse correlation between expression of tissue inhibitor of metalloproteinase-2 and invasive ability, and a significant positive correlation between expressions of matrix metalloproteinase-1, vimentin, and p-Src (pY416) in these cell lines and their invasiveness (all p<0.05).
CONCLUSION: The subline model may be used to study the molecular and genetic mechanisms underlying the invasion and metastasis of ESCC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20392990

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  YAP1 acts as a negative regulator of pro-tumor TAZ expression in esophageal squamous cell carcinoma.

Authors:  Yi-Zih Kuo; Ya-Rong Kang; Wei-Lun Chang; Lydia Chin-Ling Sim; Tzu-Chin Hsieh; Chu-Han Chang; Yi-Ching Wang; Ching-Jung Tsai; Li-Chun Huang; Sen-Tien Tsai; Li-Wha Wu
Journal:  Cell Oncol (Dordr)       Date:  2022-08-05       Impact factor: 7.051

2.  Overexpression of ATPase Na+/+ transporting alpha 1 polypeptide, ATP1A1, correlates with clinical diagnosis and progression of esophageal squamous cell carcinoma.

Authors:  I-Chen Wu; Yu-Kuei Chen; Chun-Chieh Wu; Yu-Jen Cheng; Wei-Chung Chen; Huey-Jiun Ko; Yu-Peng Liu; Chee-Yin Chai; Hung-Shun Lin; Deng-Chyang Wu; Ming-Tsang Wu
Journal:  Oncotarget       Date:  2016-12-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.